Nyxoah SA
Develops hypoglossal neurostimulation therapy for Obstructive Sleep Apnea (OSA).
NYXH | BR
Overview
Corporate Details
- ISIN(s):
- BE0974358906
- LEI:
- 5493002O1ESKZ18OXR80
- Country:
- Belgium
- Address:
- Rue Edouard Belin 12, 1435 Mont-Saint-Guibert
- Website:
- https://www.nyxoah.com/
- Sector:
- Manufacturing
Description
Nyxoah SA is a medical technology company focused on the development and commercialization of solutions for Obstructive Sleep Apnea (OSA). The company's lead product is the Genio® system, a hypoglossal neurostimulation (HNS) therapy designed for patients with moderate to severe OSA. The system features a patient-centered, leadless, and battery-free implantable stimulator. It functions by providing bilateral stimulation to the hypoglossal nerve, which controls tongue muscles, to maintain an open airway during sleep.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-11-19 07:00 |
Nyxoah - SSM 2024 - Form for voting by mail - ENG FR.pdf
|
French | 248.0 KB | ||
| 2024-11-19 07:00 |
Nyxoah - SSM 2024 - Attendance notification form - ENG FR.pdf
|
French | 196.1 KB | ||
| 2024-11-19 07:00 |
Nyxoah - SSM 2024 convening notice - PR (ENG).pdf
|
English | 257.8 KB | ||
| 2024-11-19 07:00 |
Nyxoah - SSM 2024 convening notice - PR (FR).pdf
|
French | 288.5 KB | ||
| 2024-11-18 22:30 |
2024 11 18 PR Transparency notification 2024 11 (Resmed) (ENG).pdf
|
English | 144.3 KB | ||
| 2024-11-18 22:30 |
2024 11 18 PR Transparency notification 2024 11 (Resmed) (FR).pdf
|
French | 144.3 KB | ||
| 2024-11-06 22:05 |
Nyxoah Q3 2024 financial report (FR) (FINAL).pdf
|
French | 785.7 KB | ||
| 2024-11-06 22:05 |
ENGLISH_Q3 2024 Earnings PR.pdf
|
English | 259.3 KB | ||
| 2024-11-06 22:05 |
FRENCH_Q3 2024 Earnings PR.pdf
|
French | 335.2 KB | ||
| 2024-11-06 22:05 |
Nyxoah Reports Third Quarter Financial and Operating Results
|
English | 55.3 KB | ||
| 2024-11-05 10:00 |
Nyxoah kundigt Teilnahme an der Munchner Kapitalmarkt Konferenz und dem Deutsch…
|
German | 12.3 KB | ||
| 2024-10-25 22:30 |
2024 10 25 PR Transparency notifications 2024 10 (Vestal Point) (ENG).pdf
|
English | 168.2 KB | ||
| 2024-10-25 22:30 |
2024 10 25 PR Transparency notifications 2024 10 (Vestal Point) (FR).pdf
|
French | 193.4 KB | ||
| 2024-10-15 22:30 |
2024 10 15 PR Transparency notifications 2024 10 (Jürgen Hambrecht BlackRock) (…
|
English | 204.2 KB | ||
| 2024-10-15 22:30 |
2024 10 15 PR Transparency notifications 2024 10 (Jürgen Hambrecht BlackRock) (…
|
French | 205.4 KB |
Automate Your Workflow. Get a real-time feed of all Nyxoah SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Nyxoah SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Nyxoah SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-11-19 | Laurette Renard | Close relation | Sell | 5,000 | 39,000.00 EUR |
| 2024-09-05 | Hambrecht Jürgen | Board | Sell | 980,000 | 6,840,400.00 EUR |
| 2024-09-05 | JH Capital GmbH | Close relation | Buy | 980,000 | 6,840,400.00 EUR |
| 2024-01-25 | Tompkins Patrick | Executive member | Buy | 2,000 | 18,020.00 USD |
| 2023-12-28 | Onkelinx Bruno | Executive member | Buy | 470 | 2,035.10 EUR |
| 2023-08-18 | Moreau Loïc | Executive member | Buy | 6,427 | 48,416.52 EUR |
| 2023-08-14 | Moreau Loïc | Executive member | Buy | 3,800 | 28,697.60 EUR |
| 2023-08-11 | Moreau Loïc | Executive member | Buy | 3,000 | 21,957.60 EUR |
| 2023-07-04 | Wildman Ventures LLC | Board | Buy | 25,000 | N/A |
| 2023-07-02 | Gianello Pierre | Board | Buy | 25,000 | N/A |
Peer Companies
